Studies on the immunopharmacologic properties of tris-(Chloroethyl)-amine (TS160).
D000311:Adrenal Glands / Q000473:pathology; D000707:Anaphylaxis; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D001856:Bone Marrow Examination; D005021:Ethylamines / Q000494:pharmacology* / Q000633:toxicity; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed; D007166:Immunosuppressive Agents; D007421:Intestine, Small / Q000187:drug effects; D008198:Lymph Nodes / Q000637:transplantation; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects; D011234:Precipitins; D011817:Rabbits; D051381:Rats; D013154:Spleen / Q000473:pathology; D013950:Thymus Gland / Q000473:pathology; D014181:Transplantation Immunology / Q000187:drug effects
D005021:Ethylamines; D007166:Immunosuppressive Agents; D011234:Precipitins